GPR35 and hypertensive disorder: This work is relevant to the human population because our data shows that inhibiting GPR35 protects against blood pressure elevation under a hypertensive mouse model that mimics low-renin hypertension prevalent biochemical phenotype in up to 30% of patients with hypertension, depending on age and race.55